Christopher Lee

FlowMedica, Inc. develops intravascular systems and medical devices. The company's products include Benephit CV, PVSolo, PVMini, and XT Infusion systems. It also develops novel, proprietary, and minimally invasive intravascular systems for implementing Targeted Renal Therapy. The company was founded in 2002 and is headquartered in Fremont, CA.

Remon Medical Technologies, Inc. develops and commercializes assessment and treatment implants. It has developed applications for patient management, post-operative monitoring, nerve and tissue stimulation and local drug delivery. The company was founded by Eyal Doron, Yariv Porat and Yossi Tzaliach in 1997 and is headquartered in Waltham, MA.

Vascular Therapies, Inc. operates as a biopharmaceutical firm that develops and commercialize treatments of patients requiring an AV fistula for dialysis. It provides plan on the hemodialysis vascular access indication. The company was founded by Sriram Iyer in 2001 and is headquartered in Cresskill, NJ.

CS-Keys is the leader in discovery and development of cancer diagnostics based on the science of the DNA Synthesome. As the greatest potential for reducing mortality of cancer lies in the detection of asymptomatic, early stage disease, as well as for residual disease after treatment, the discovery of new markers for this purpose holds significant promise. CS-Keys patented caPCNA antibody may be a powerful ally in helping pathologists achieve this objective. CS-Keys, Inc. is a private, Indianapolis-based biotechnology company focused on the discovery and development of 3rd generation cancer-associated biomarkers using proteomics. These biomarkers may be used to create products to enhance the diagnosis and treatment of patients with cancer. CS-Keys was founded in early 2006 to develop and commercialize products based on the founders research and licensed from Indiana University.

The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA.

X-Cell Medical, Inc. develops drugs for cardiovascular clinical applications. It focuses on delivery of drugs with safety and efficacy profiles for cardiovascular indications including restenosis, myocardial infarction and vulnerable plaque. The company was founded in 2002 and is headquartered in Monmouth Junction, NJ.

Triathlon Medical Venture Partners LLC (Triathlon Medical Venture) is a venture capital firm founded in 2004 by Dennis Costello and John Rice. The firm is headquartered in Cincinnati, Ohio with additional offices in Indianapolis and Louisville.

Covidien Unlimited Co. engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings. It operates through Medical Devices and U.S. Medical Supplies segments. The Medical Devices segment involves in the distribution of surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. The U.S. Medical Supplies segment includes marketing of nursing care, medical surgical, SharpSafety brand, and original equipment manufacturer (OEM) products. The company was founded in 1967 and is headquartered in Dublin, Ireland.

American Institute of Toxicology, Inc. operates a drug testing and toxicology laboratory. It provides custom-designed drug testing services, laboratory testing capabilities compliance testing, forensic toxicology drug testing, clinical testing, and prescription drug testing services. The company was founded by Michael A. Evans in 1990 and is headquartered in Denton, TX.

Expanding Orthopedics, Inc. develops and markets orthopedic device products. The firm’s products include XPED pedicle screw system and FLXfit 3D expandable Cage. The company was founded by Mark M. Levy in 2001 and is headquartered in Atlanta, GA.

CBSET, Inc. is a not-for-profit biomedical research institute located in Lexington, MA. The non-profit company's mission is to advance biomedical research through innovative, high-quality preclinical services to achieve the scientific, regulatory, and commercial goals of its sponsors. CBSET combines top-tier research with operational expertise by providing in vivo studies, in vitro studies, computational and 3D modeling, and complex histopathology services. The company's 40,000-foot, GLP-compliant, OLAW-assured, AAALAC-accredited facility includes vivaria, procedure rooms, catheterization/imaging labs, surgical and necropsy suites, histopathology, SEM, and a range of other technologies.

Robocath SAS develops robotics medical devices for cardiac pathologies. It allows doctors to perform coronary angioplasties by controlling the catheters whilst seating behind a control station that is protected from X-rays. The company was founded by Philippe Bencteux in 2009 and is headquartered in Rouen, France.

Xeraya Capital Sdn. Bhd. (Xeraya Capital) is a venture capital firm founded in 2006 by Amirul Fares Wan Zahir. The firm is headquartered in Kuala Lumpur, Malaysia.

Khazanah Nasional Bhd. (Private Equity) (Khazanah Nasiona) is a Private Equity firm, a subsidiary of Khazanah Nasional Bhd. founded in 1994. The firm is headquartered in Malaysia.

Gradient Denervation Technologies SAS engages in research and development in other physical and natural sciences. The company is headquartered in Paris, France.